"Potential" for 2002 FluMist launch

A complete response letter sent to MEDI by FDA leaves open the "potential" for approval of FluMist in time for the 2002 influenza season, MEDI CEO David Mott said on Thursday. Mott added that he is "very confident of the approvability

Read the full 413 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE